Our results indicated that CUR and BBR treatment alone slightly increased the protein levels of p-JNK and Beclin1 and decreased p-Bcl-2 levels in the two breast cancer cell lines, while co-treatment of these two compounds remarkably enhanced the regulatory effects on these proteins (Fig. 7A). This evidence concerns the gene BECN1 and breast carcinoma.